Literature DB >> 16433619

Defined conditions for development of functional hepatic cells from human embryonic stem cells.

Robert E Schwartz1, Jonathan L Linehan, Matthew S Painschab, Wei-Shou Hu, Catherine M Verfaillie, Dan S Kaufman.   

Abstract

Human embryonic stem (hES) cells provide an important means to evaluate specific soluble and cell-bound stimuli that regulate development of specific cell lineages. Here, we examined specific cytokines and extracellular matrix (ECM) proteins that support differentiation of hES cells to hepatocytes. Tests of several different conditions determined that addition of fibroblast growth factor (FGF)-4 and hepatocyte growth factor in completely serum-free cultures of hES cell-derived embryoid bodies subsequently allowed to attach to type I collagen-coated dishes led to maximal differentiation into cells, not only with the morphologic and phenotypic characteristics of hepatocytes but also the functional characteristics. Expression of common hepatic transcription factors including HNF-3beta, HNF-1, and GATA-4 were all significantly induced under these conditions. Hepatocyte function was demonstrated by multiple complementary criteria: production of urea and albumin, phenobarbital-induced cytochrome P450 expression, and uptake of indocyanine green. These hES cell-derived hepatocytes will serve as a resource to understand normal human hepatocyte development and for applications such as cell replacement therapies and screening of pharmacologic drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16433619     DOI: 10.1089/scd.2005.14.643

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  40 in total

1.  Isolation and characterization of porcine visceral endoderm cell lines derived from in vivo 11-day blastocysts.

Authors:  Neil C Talbot; Le Ann Blomberg; Ayesha Mahmood; Thomas J Caperna; Wesley M Garrett
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-03-16       Impact factor: 2.416

Review 2.  Potentials of regenerative medicine for liver disease.

Authors:  Shinichiro Ogawa; Shinichi Miyagawa
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

3.  Pluripotent stem cells to hepatocytes, the journey so far.

Authors:  Anwar A Palakkan; Jyoti Nanda; James A Ross
Journal:  Biomed Rep       Date:  2017-03-01

Review 4.  Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-05       Impact factor: 5.187

5.  Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen.

Authors:  Meredith B Jones; Chia H Chu; James C Pendleton; Michael J Betenbaugh; Joseph Shiloach; Bolormaa Baljinnyam; Jeffrey S Rubin; Michael J Shamblott
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

6.  In vitro models for liver toxicity testing.

Authors:  Valerie Y Soldatow; Edward L Lecluyse; Linda G Griffith; Ivan Rusyn
Journal:  Toxicol Res (Camb)       Date:  2012-11-23       Impact factor: 3.524

7.  Design of stable and uniform single nanoparticle photonics for in vivo dynamics imaging of nanoenvironments of zebrafish embryonic fluids.

Authors:  Prakash D Nallathamby; Kerry J Lee; Xiao-Hong Nancy Xu
Journal:  ACS Nano       Date:  2008-07       Impact factor: 15.881

Review 8.  Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

Authors:  Michael Sinz; Gillian Wallace; Jasminder Sahi
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

Review 9.  Engineering tissue from human embryonic stem cells.

Authors:  C M Metallo; S M Azarin; L Ji; J J de Pablo; S P Palecek
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

Review 10.  In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art.

Authors:  Sarah Snykers; Joery De Kock; Vera Rogiers; Tamara Vanhaecke
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.